Table 2.
Presentation and clinical characteristics for IVUS-assisted TEVAR group
| Patient number | Sex/age (years) | Coexisting conditions | Time since diagnosis | Symptoms | Treatment | Follow-up duration |
|---|---|---|---|---|---|---|
| 1 | Male/66 | Hypertension | 35 days | Chest pain | TEVAR (Talent) | 19 months |
| 2 | Male/43 | Hypertension | 67 days | Chest pain, abdominal pain | TEVAR (Zenith) | 34 months |
| 3 | Male/38 | Hypertension | 2 years | Chest pain | TEVAR (Valiant) | 22 months |
| 4 | Male/55 | Marfan syndrome | Postsurgery for 15 years Post-TEVAR for 7 years | Abdominal pain | TEVAR (Valiant) | 21 months |
| 5 | Male/31 | None | 13 days | Chest pain | Aorta-IA + LCCA, TEVAR (Zenith) | 36 months |
| 6 | Male/53 | Hypertension | Post-TEVAR for 5 years | Chest pain | RCCA-LCCA, TEVAR (Valiant) | 32 months |
| 7 | Female/63 | Hypertension | 20 days | Chest pain | TEVAR (Zenith) | 27 months |
| 8 | Male/48 | Hypertension | 14 days | Chest pain | TEVAR (Valiant) + chimney | 29 months |
| 9 | Male/50 | Hypertension | 13 days | Chest pain | TEVAR (Captivia) | 34 months |
| 10 | Male/31 | Hypertension | 1day | Chest pain | TEVAR (Zenith) + SMA stent | 64 days (died) |
| 11 | Male/69 | Hypertension | 16 days | Chest pain | TEVAR (Valiant) | 29 months |
| 12 | Male/47 | Hypertension | 15 days | Chest pain, abdominal pain | TEVAR (Zenith) | 21 months |
| 13 | Female/42 | Hypertension | 14 days | Chest pain | TEVAR (Valiant) | 15 months |
TEVAR: Thoracic endovascular aortic repair; IA: Innominate artery; LCCA: Left common carotid artery; RCCA: Right common carotid artery; SMA: Superior mesenteric artery; IVUS: Intravascular ultrasound.